A Study of TG103 Injection in Overweight or Obesity

NCT05299697 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

195

Enrollment

INDUSTRY

Sponsor class

Conditions

Overweight or Obesity

Interventions

DRUG: TG103 15 mg
DRUG: TG103 22.5 mg
DRUG: Placebo

Sponsor

CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.